Hanson & Doremus Investment Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28K Sell
434
-229
-35% -$15.1K ﹤0.01% 363
2026
Q1
$47K Sell
663
-326
-33% -$25.7K 0.01% 340
2025
Q4
$81K Buy
989
+262
+36% +$20.4K 0.01% 279
2025
Q3
$55K Sell
727
-207
-22% -$15.4K 0.01% 319
2025
Q2
$69K Buy
934
+82
+10% +$5.71K 0.01% 293
2025
Q1
$69K Buy
852
+142
+20% +$12.2K 0.01% 288
2024
Q4
$56K Sell
710
-42
-6% -$3.57K 0.01% 293
2024
Q3
$71K Sell
752
-85
-10% -$7.13K 0.01% 273
2024
Q2
$65K Sell
837
-130
-13% -$10.6K 0.01% 276
2024
Q1
$88K Sell
967
-48
-5% -$3.99K 0.02% 259
2023
Q4
$78K Sell
1,015
-78
-7% -$5.46K 0.01% 267
2023
Q3
$74K Hold
1,093
0.02% 263
2023
Q2
$89K Sell
1,093
-257
-19% -$20.5K 0.02% 243
2023
Q1
$111K Buy
+1,350
New +$96.4K 0.02% 224

Other funds holding GEHC

Hanson & Doremus Investment Management's GEHC Position: Q2 2026 in Review

Hanson & Doremus Investment Management reduced its GE HealthCare (GEHC) stake by 35% in Q2 2026, selling an estimated $15.1K and leaving 434 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #363.

Hanson & Doremus Investment Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $111K in Q1 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Hanson & Doremus Investment Management held 434 shares of GE HealthCare worth $28K as of Q2 2026.
  • Hanson & Doremus Investment Management sold 229 GE HealthCare shares in Q2 2026, an estimated $15.1K.
  • GE HealthCare made up ﹤0.01% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #363 holding.
  • Hanson & Doremus Investment Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Hanson & Doremus Investment Management's GE HealthCare position peaked at $111K in Q1 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.